Adipose-derived stem cells, explained

Adipose-derived stem cells are mesenchymal stem cells taken from your own fat through a small liposuction, then injected back into you the same day. Every guide we write here starts from what a clinic is actually selling, and adipose is sold on convenience. Fat is easy to reach, and a gram of it carries far more mesenchymal stem cells than a gram of bone marrow. No adipose product is FDA approved for arthritis or any orthopedic use, and in 2024 a federal appeals court agreed with the FDA that the version most clinics sell is a drug.

Adipose sits alongside our BMAC guide, which covers the bone marrow route, and mesenchymal stem cells, the cell type both procedures are after.

What Adipose-Derived Stem Cells Are

Adipose-derived stem cells are the mesenchymal stem cells that live in the connective tissue holding your fat together, not in the fat cells themselves. Fat is one of the three sources clinics use, next to bone marrow and donated umbilical cord tissue, and our sources guide puts the three side by side.

A clinic rarely injects pure stem cells. The injection is a mixed population called the stromal vascular fraction (SVF): mesenchymal stem cells plus immune cells, cells from small blood vessels, and connective tissue cells, suspended in saline. Some clinics inject processed fat with the stem cells still inside it, sometimes labeled a fat graft or micro-fat transfer. Ask which of the two you are being quoted, because processing turns a routine fat graft into a product the FDA treats as a drug.

How the Procedure Works

An adipose procedure runs in three steps in a single outpatient visit.

1. Harvest. A provider numbs a fatty area, usually the abdomen or flank, and draws out fat through a small liposuction cannula. This takes longer and leaves more soreness than a marrow draw.
2. Processing. The fat is separated, either mechanically by shaking, filtering and spinning, or chemically with an enzyme called collagenase that digests the tissue and frees more cells.
3. Injection. The result goes into the target joint or tissue, usually with ultrasound guidance, or into a vein for systemic conditions.

The enzyme in step two is the whole legal argument. Mechanical processing keeps the tissue closer to its original state. Enzymatic digestion pulls cells out of the structure they came from, so the FDA treats the output as something manufactured rather than something transferred.

Why the FDA Calls SVF a Drug

The FDA’s position is that turning fat into SVF creates a product needing approval before sale, and a federal appeals court has now backed that reading. Clinics have long relied on the “same surgical procedure” exception in 21 CFR 1271.15(b), which exempts a provider who removes tissue from a patient and puts it back into that same patient during the same operation. On that reading, a fat harvest and a same-day injection are one procedure and the FDA has no say.

The government sued the California Stem Cell Treatment Center and the Cell Surgical Network over exactly that claim. A district judge accepted the clinics’ reading in 2022. On 27 September 2024 the Ninth Circuit reversed, holding that the SVF product does not fall inside the same surgical procedure exception and is subject to regulation as a drug.

For a patient, the ruling changes one thing. It does not make SVF unsafe or ineffective. It removes the legal cover a clinic uses when it tells you the treatment is “not regulated because it is your own tissue”. Our FDA status guide walks through the exemption and how to check what a specific clinic claims.

Fat Versus Bone Marrow

Both sources are after the same cell type. The differences that actually reach you are the harvest, the yield, and the evidence base.

Neither column is a recommendation to buy. If a clinic tells you fat is better because the cell count is higher, ask which trial in your condition showed that the extra cells produced a better outcome.

What the Evidence Shows

The largest placebo-controlled trial of fat-derived cells in knee osteoarthritis found no benefit. The ADIPOA2 phase 2b trial was published in Annals of the Rheumatic Diseases in August 2025. It randomized 135 adults aged 45 to 70 across nine European centers. Each received one injection, either of laboratory-expanded cells grown from their own fat or of saline placebo. Pain and function scores came out no better in the treated group. Those cells were cultured to a controlled dose under trial conditions, which is a more consistent product than the same-day preparation a US clinic makes in an afternoon.

Smaller trials have reported gains, which is why clinic websites can cite published research and still be selling something unproven. A Cochrane review of stem cell injections for knee osteoarthritis rated the overall evidence low-certainty, meaning the true effect could be substantially different from what the trials report. When a well-run randomized trial finds nothing and a small case series finds a lot, the larger negative result is the one to weigh.

Safety and Recovery

Most of the risk in an adipose procedure comes from the liposuction rather than the injection. Expect bruising, swelling and soreness at the harvest site for several days, longer than a marrow draw leaves. Less commonly, the harvest can bleed, collect fluid, or become infected. The injection itself carries the usual short-lived pain and inflammatory flare, and our safety guide covers the rarer serious events reported across all sources.

One risk is specific to unapproved products. Because no SVF preparation is licensed, nobody has reviewed the manufacturing at the clinic treating you, so sterility rests on that clinic’s own practice. Ask how the sample is processed, in what kind of space, and by whom.

What This Costs

Adipose procedures fall inside the $3,000 to $8,000 per joint range US clinics charge for stem cell injections, and the liposuction step lifts many quotes above the low end of it. No insurer, Medicare or Medicaid plan covers any of it, because every one of them classifies these injections as experimental. The full picture by joint is in our stem cell injection cost guide.

Get an itemized quote. Ask for the total cost of the plan the clinic recommends. The price of one injection is not the number you are deciding on, because a “course” of three quietly triples the figure you were quoted on the phone.

Who This Is Not For

An adipose procedure is a poor fit if you are thin. A harvest needs a usable volume of fat, and a lean patient may end up with a larger or more uncomfortable liposuction to get it, which is a real cost for an unproven benefit. It is also the wrong choice if you are on a blood thinner or have a bleeding disorder, where any liposuction raises the stakes. If your goal is the shortest recovery, BMAC leaves less soreness behind, and if your goal is proven arthritis care, physical therapy and weight management still have the stronger evidence and a fraction of the price.

What Would Change Our Answer

An FDA-licensed adipose product for an orthopedic use would change this most, because approval brings manufacturing standards along with it. A large placebo-controlled trial reversing the ADIPOA2 result would change the evidence read. A published head-to-head against bone marrow in the same patients would settle the source question that clinics currently answer with cell counts. None of those has happened as of September 2026.

What To Do Next

Ask any clinic offering adipose-derived stem cells for four answers in writing.

1. Is the product SVF or a fat graft?
2. Is the processing mechanical or enzymatic?
3. What is the total cost of the recommended course, not one injection?
4. Which published trial supports this use in my condition?

Take those answers to our clinic vetting guide, and price the alternatives at the same time so the comparison is real.